Insider Transactions in Q1 2022 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2022
|
Phillip A Sharp Director |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$4,500,000
$150.0 P/Share
|
|
Feb 09
2022
|
Phillip A Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$330,000
$11.33 P/Share
|
|
Feb 02
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,518
-30.2%
|
$218,592
$144.67 P/Share
|
|
Feb 01
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,026
+50.0%
|
-
|